4/A//SEC Filing
Josephson Neil 4/A
Accession 0000899243-22-039331
CIK 0001937653other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 8:00 PM ET
Size
13.3 KB
Accession
0000899243-22-039331
Insider Transaction Report
Form 4/AAmended
Zymeworks Inc.ZYME
Josephson Neil
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2022-11-10−5,885→ 11,772 total→ Common Shares (5,885 underlying) - Sale
Common Stock
2022-11-10$8.10/sh−2,475$20,045→ 14,449 total - Exercise/Conversion
Common Stock
2022-11-10+5,885→ 16,924 total
Footnotes (5)
- [F1]Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on November 10, 2021.
- [F2]Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (the "Grant Agreement"), effective on the grant date of the RSUs, the Reporting Person adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.09 to $8.10, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F4]Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F5]The RSUs were granted on November 10, 2021 and vest in three equal annual instalments beginning on November 10, 2022.
Documents
Issuer
Zymeworks Inc.
CIK 0001937653
Entity typeother
Related Parties
1- filerCIK 0001864141
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 8:00 PM ET
- Size
- 13.3 KB